Krishnan Viswanadhan
Director/Board Member at CARGO THERAPEUTICS, INC.
Net worth: - $ as of 2024-04-29
Krishnan Viswanadhan active positions
Companies | Position | Start | End |
---|---|---|---|
CARGO THERAPEUTICS, INC. | Director/Board Member | 2022-09-30 | - |
Independent Dir/Board Member | 2022-09-30 | - | |
JW (CAYMAN) THERAPEUTICS CO. LTD | Director/Board Member | 2019-11-19 | - |
Independent Dir/Board Member | 2023-08-28 | - | |
JW Therapeutics (Shanghai) Co., Ltd.
JW Therapeutics (Shanghai) Co., Ltd. BiotechnologyHealth Technology JW Therapeutics (Shanghai) Co., Ltd. engages in biopharmaceutical industry. It focuses on the development, transformation, and promotion of cell-based immunotherapies to treat cancer. The company was founded by Yi Ping Li on February 18, 2016 and is headquartered in Shanghai, China. | Director/Board Member | - | - |
Be Biopharma, Inc.
Be Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Be Biopharma, Inc. develops engineered B cells as a new category of cellular medicines. The company was founded by David Steinberg, Aleks Radovic-Moreno and Lea Hachigian and is headquartered in Cambridge, MA. | Chief Operating Officer | 2021-06-30 | - |
President | 2021-06-30 | - |
Career history of Krishnan Viswanadhan
Former positions of Krishnan Viswanadhan
Companies | Position | Start | End |
---|---|---|---|
CELGENE | Corporate Officer/Principal | 2017-12-31 | 2019-07-31 |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 2002-06-30 | - |
Training of Krishnan Viswanadhan
Cornell University | Masters Business Admin |
Rutgers State University of New Jersey | Doctorate Degree |
Statistics
International
United States | 5 |
China | 3 |
France | 2 |
Operational
Director/Board Member | 3 |
Independent Dir/Board Member | 2 |
Corporate Officer/Principal | 2 |
Sectoral
Health Technology | 6 |
Consumer Services | 3 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
CARGO THERAPEUTICS, INC. | Health Technology |
JW (CAYMAN) THERAPEUTICS CO. LTD | Health Technology |
Private companies | 4 |
---|---|
JW Therapeutics (Shanghai) Co., Ltd.
JW Therapeutics (Shanghai) Co., Ltd. BiotechnologyHealth Technology JW Therapeutics (Shanghai) Co., Ltd. engages in biopharmaceutical industry. It focuses on the development, transformation, and promotion of cell-based immunotherapies to treat cancer. The company was founded by Yi Ping Li on February 18, 2016 and is headquartered in Shanghai, China. | Health Technology |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Health Technology |
Be Biopharma, Inc.
Be Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Be Biopharma, Inc. develops engineered B cells as a new category of cellular medicines. The company was founded by David Steinberg, Aleks Radovic-Moreno and Lea Hachigian and is headquartered in Cambridge, MA. | Commercial Services |
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Stock Market
- Insiders
- Krishnan Viswanadhan
- Experience